21.10.2020 • NewsUPM Biochemicals

UPM Builds German Biochemicals Plant

Finnish forest industry group UPM has started construction of a bio-based monoethylene glycol/monopropylene glycol (MEG/MPG) plant in Leuna, Germany, marking a “major milestone in its strategic transformation.”

The Helsinki-headquartered company is investing €550 million in the facility, which is expected to start up by the end of 2022. Capacity will be 220,000 t/y of bioMEG and lignin-based renewable functional fillers. Output will also include bioMPG and industrial sugars made from sustainably harvested beechwood sourced regionally in Germany.

UPM said the 100% wood-based biochemicals will enable a switch from fossil-based products in a variety of end-uses. Application areas for bioMEG include textiles, PET bottles, packaging and deicing fluids. Bio-MPG is used in composites, pharmaceuticals, cosmetics and detergents. According to UPM, the global glycols market represents more than 30 million t in size and is expected to grow by about 4% per year.

Lignin-based renewable functional fillers are used in a variety of rubber applications such as tires and sealings as a sustainable alternative to carbon black and silica. UPM said the global market for carbon black and silica combined is more than 15m t with a forecast annual growth of about 3%.

“The biorefinery in Leuna will be the nucleus for an entirely new and high-value growth business and opens totally new markets for UPM with large growth potential for the future,” said Jyrki Ovaska, UPM’s executive vice president technology.

Molecular bioproducts form one of UPM’s three strategic focus areas for growth – the others are pulp and specialty packaging materials. Having entered the biofuels business, the company has turned its sights on creating a new and sustainable business in biochemicals, which it said are in very limited supply. 

UPM believes that a combination of good availability of sustainable wood supply (from forest thinning and residues from regional sawmills), unique technology, integration into the existing infrastructure at Leuna as well as proximity to customers will ensure the competitiveness of its operations.

Author: Elaine Burridge, Freelance Journalist

Finland’s UPM has started construction of a bio-based monoethylene...
Finland’s UPM has started construction of a bio-based monoethylene glycol/monopropylene glycol plant in Leuna, Germany, marking a “major milestone in its strategic transformation.” The company is investing €550 million in the 220,000 t/y facility, which is due online by end 2022. (c) UPM

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.